Complications Associated With Use of Bone-Morphogenetic Proteins in Spinal Fusion Procedures—Reply
- Kevin S. Cahill, MD, PhD, MPH kcahill3@partners.org;
- Elizabeth B. Claus, MD, PhDDepartment of NeurosurgeryBrigham and Women's HospitalBoston, Massachusetts
Since this article does not have an abstract, we have provided the first 150 words of the full text.
- KEYWORDS:
- BACK PAIN
- BONE MORPHOGENETIC PROTEINS
- BONE RESORPTION
- HOSPITAL CHARGES
- LENGTH OF STAY
- ORTHOPEDIC PROCEDURES
- POSTOPERATIVE COMPLICATIONS
- SPINAL FUSION
In Reply: We thank Dr Smoljanovic and colleagues for their comments regarding complications associated with BMP usage. As we noted in our article, the available data did not allow us to address the correlation between dosage of BMP and complication rate. We agree that additional work is needed to clarify the short-term and long-term complications associated with different dosages of BMP.
Financial Disclosures: None reported.
Letters Section Editor: Robert M. Golub, MD, Senior Editor.
